Literature DB >> 25039748

Quantification of rare NPM1 mutation subtypes by digital PCR.

Ulrike Bacher1, Frank Dicker, Claudia Haferlach, Tamara Alpermann, Dominic Rose, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger.   

Abstract

Entities:  

Keywords:  digital PCR; minimal residual disease (MRD); rare NPM1 mutation subtypes; real-time PCR

Mesh：

Substances：

Year:  2014        PMID： 25039748     DOI： 10.1111/bjh.13038

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  Direct comparison of quantitative digital PCR and 2-hydroxyglutarate enantiomeric ratio for IDH mutant allele frequency assessment in myeloid malignancy.

Authors:  D H Wiseman; E A Struys; D P Wilks; C I Clark; M W Dennis; E E W Jansen; G S Salomons; T C P Somervaille
Journal:  Leukemia       Date:  2015-06-19       Impact factor: 11.528

2.  Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.

Authors:  Fei Yang; Tauangtham Anekpuritanang; Richard D Press
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

3.  Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations.

Authors:  Nuria Mencia-Trinchant; Yang Hu; Maria Antonina Alas; Fatima Ali; Bas J Wouters; Sangmin Lee; Ellen K Ritchie; Pinkal Desai; Monica L Guzman; Gail J Roboz; Duane C Hassane
Journal:  J Mol Diagn       Date:  2017-05-16       Impact factor: 5.568

Review 4.  Methods of Detection of Measurable Residual Disease in AML.

Authors:  Yi Zhou; Brent L Wood
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

Review 5.  Secondary mutations as mediators of resistance to targeted therapy in leukemia.

Authors:  Naval Daver; Jorge Cortes; Farhad Ravandi; Keyur P Patel; Jan A Burger; Marina Konopleva; Hagop Kantarjian
Journal:  Blood       Date:  2015-03-20       Impact factor: 22.113

Review 6.  MRD in AML: does it already guide therapy decision-making?

Authors:  Gert Ossenkoppele; Gerrit Jan Schuurhuis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 7.  Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

Review 8.  Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.

Authors:  Fabio Forghieri; Patrizia Comoli; Roberto Marasca; Leonardo Potenza; Mario Luppi
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

9.  Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.

Authors:  Nikhil Patkar; Rohan Kodgule; Chinmayee Kakirde; Goutham Raval; Prasanna Bhanshe; Swapnali Joshi; Shruti Chaudhary; Y Badrinath; Sitaram Ghoghale; Shraddha Kadechkar; Syed Hasan Khizer; Sadhana Kannan; Dhanalaxmi Shetty; Anant Gokarn; Sachin Punatkar; Hasmukh Jain; Bhausaheb Bagal; Hari Menon; Manju Sengar; Navin Khattry; Prashant Tembhare; Papagudi Subramanian; Sumeet Gujral
Journal:  Oncotarget       Date:  2018-11-27

10.  Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells.

Authors:  Serena Travaglini; Daniela Francesca Angelini; Valentina Alfonso; Gisella Guerrera; Serena Lavorgna; Mariadomenica Divona; Anna Maria Nardozza; Maria Irno Consalvo; Emiliano Fabiani; Marco De Bardi; Benedetta Neri; Fabio Forghieri; Francesco Marchesi; Giovangiacinto Paterno; Raffaella Cerretti; Eva Barragan; Valentina Fiori; Sabrina Dominici; Maria Ilaria Del Principe; Adriano Venditti; Luca Battistini; William Arcese; Francesco Lo-Coco; Maria Teresa Voso; Tiziana Ottone
Journal:  Blood Cancer J       Date:  2020-08-25       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.